iPhone 17 Demand Lifts AAPL Supercycle, AI & Innovation "Question Mark" — Positive

AAPL   Schwab Network — January 09, 2026

The holiday season added muscle to Apple's (AAPL) iPhone 17 sales. @LikeFolio's data shows strong demand in the tail-end of 2025, something Megan Brantley believes offers a good set-up for 2026.

image for news iPhone 17 Demand Lifts AAPL Supercycle, AI & Innovation "Question Mark"

CANTON, Ga., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation's leading builder of luxury homes, today announced the release of two new home designs at Aurora Ridge at Great Sky, a premier community by Toll Brothers in the scenic hills of Cherokee County, Georgia.

image for news Toll Brothers Announces the Release of New Ranch Home Designs at Aurora Ridge at Great Sky in Canton, Georgia

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming January 12, 2026 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Stride, Inc. (“Stride” or the “Company”) (NYSE: LRN) securities between October 22, 2024 and October 28, 2025, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO LOST MONEY ON STRIDE, INC. (LRN), CLICK HERE TO PARTICIPATE IN THE SECURITIES FRAUD.

image for news Deadline Soon: Stride, Inc. (LRN) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

Olin: Shares Brush Off A Negative Preannouncement — Negative

OLN   Seeking Alpha — January 09, 2026

Olin Corporation remains a "Buy" as shares trade at a compressed ~9x mid-cycle earnings, despite recent operational setbacks. The Q4 EBITDA miss is primarily due to one-time maintenance overruns at Freeport; operations have since normalized, but capex may need to rise to sustainable levels. Demand headwinds persist, especially from weak Chinese and U.S. construction, with 2026 results expected to be flat or slightly lower versus 2025.

image for news Olin: Shares Brush Off A Negative Preannouncement

3 Reasons Why You Should Keep Owning Realty Income In 2026 — Positive

O   Seeking Alpha — January 09, 2026

Realty Income offers a highly diversified, resilient tenant portfolio across 92 industries, limiting exposure to any single client or sector. O maintains a 5.6% yield with a strong history of monthly dividend growth, supported by robust AFFO and FFO performance. Valuation models indicate O's fair value is $63–$71.5 per share, implying 11%–25% upside from current levels.

image for news 3 Reasons Why You Should Keep Owning Realty Income In 2026

Here's Why Investors Should Retain Euronet Stock for Now — Positive

EEFT   Zacks Investment Research — January 09, 2026

EEFT's transaction growth, global expansion, acquisitions and digital payment push support its long-term outlook despite recent share declines.

image for news Here's Why Investors Should Retain Euronet Stock for Now

Visa's Tokenization Push Is Becoming More Than a Security Play — Positive

V   Zacks Investment Research — January 09, 2026

V's tokenization push is evolving beyond security, boosting transaction efficiency, AI-driven insights and seamless payments across devices.

image for news Visa's Tokenization Push Is Becoming More Than a Security Play

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Varonis Systems, Inc. (“Varonis” or the “Company”) (NASDAQ: VRNS) common stock between February 4, 2025 and October 28, 2025, inclusive (the “Class Period”). Varonis investors have until March 9, 2026 to file a lead plaintiff motion. IF YOU SUFFERED A LOSS ON.

image for news Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages Varonis Systems, Inc. (VRNS) Shareholders To Inquire About Securities Fraud Class Action

NASHVILLE, Tenn.--(BUSINESS WIRE)--The spirit of Music City was on full display on New Year's Eve as indie music venue Anzie Blue and Honda Powersports partnered to present Anzie Blue New Year's Eve Live, a first-time musical event featuring a genre-spanning lineup that was seen worldwide. The six-hour event was livestreamed on CNN.com, with select performances airing live on CNN as part of its daytime coverage of New Year's Eve from cities around the world. Hosted by CNN anchor Lynda Kinkade,.

image for news Nashville's Anzie Blue and Honda Powersports Wrap 2025 With Global New Year's Eve, Star-studded Musical Event Highlighting the Best of Music City

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming January 12, 2026 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Freeport-McMoran Inc. (“Freeport” or the “Company”) (NYSE: FCX) securities between February 15, 2022 and September 24, 2025, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO LOST MONEY ON FREEPORT-MCMORAN INC. (FCX), CLICK HERE TO PARTICIPATE I.

image for news Deadline Soon: Freeport-McMoran Inc. (FCX) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

New York, New York, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Oak Hill Advisors (“OHA”) served as Administrative Agent and Lead Left Arranger for a private unitranche financing supporting Majesco's acquisition of Vitech Systems Group (“Vitech”) and a concurrent refinancing. Majesco, a portfolio company of Thoma Bravo, is a leading provider of cloud-native, AI-native software for insurers in the property and casualty (P&C) and life, annuity and health (L&AH) sectors. Vitech is a complementary provider of cloud-native pension and benefits administration software.

image for news UPDATE - OHA Leads Private Debt Financing Supporting Majesco's Acquisition of Vitech

Jazz Pharmaceuticals: A Strong Buy Due To Execution In Oncology — Positive

JAZZ   Seeking Alpha — January 09, 2026

Jazz Pharmaceuticals plc is deeply undervalued, trading at 2.4x sales, as the market overlooks its oncology pivot and robust growth catalysts. Ziihera's Phase 3 data surpassing Herceptin signals a transformative 'pipeline in a product' opportunity, targeting multi-billion-dollar HER2+ cancer market. Zepzelca's expanded front-line SCLC approval and Epidiolex's blockbuster trajectory underpin near-term revenue growth and portfolio diversification.

image for news Jazz Pharmaceuticals: A Strong Buy Due To Execution In Oncology

USA Rare Earth Crosses 50-Day SMA: Should You Buy the Stock Now? — Positive

USAR   Zacks Investment Research — January 09, 2026

USAR crosses its 50-day SMA as shares climb 52% in six months, with Stillwater magnet plant advances and a $400M cash boost driving momentum.

image for news USA Rare Earth Crosses 50-Day SMA: Should You Buy the Stock Now?

Pagaya Shines in 2025: How Should Investors Play the Fintech Stock? — Positive

PGY   Zacks Investment Research — January 09, 2026

PGY hit a 2025 inflection point with three straight GAAP profits, shrinking credit losses and a 125% share surge amid stronger fundamentals.

image for news Pagaya Shines in 2025: How Should Investors Play the Fintech Stock?

RPM Q2 Earnings & Sales Miss Estimates, Adjusted EBIT Down Y/Y — Negative

RPM   Zacks Investment Research — January 09, 2026

RPM International posts a Q2 earnings and sales miss as costs pressure margins, though acquisitions lift revenues and management sees improvement ahead.

image for news RPM Q2 Earnings & Sales Miss Estimates, Adjusted EBIT Down Y/Y

Looking for a Growth Stock? 3 Reasons Why Commercial Metals (CMC) is a Solid Choice — Positive

CMC   Zacks Investment Research — January 09, 2026

Commercial Metals (CMC) is well positioned to outperform the market, as it exhibits above-average growth in financials.

image for news Looking for a Growth Stock? 3 Reasons Why Commercial Metals (CMC) is a Solid Choice

Wall Street Roundup: Is Everything Priced In But Normalcy? — Neutral

BAC  C  CAT  DAL  GS  HAL  IIPR  JBHT  META  MU  OKLO  RBLX  SNDK  VST  WFC   Seeking Alpha — January 09, 2026

AI-driven demand is fueling outsized gains in memory, storage, and power infrastructure stocks, with SNDK up 71% in a month and MU up 230% in 2025. Geopolitical events, notably US action in Venezuela, boosted oil and defense stocks, but pressured Canadian oil sands due to heavy crude competition.

image for news Wall Street Roundup: Is Everything Priced In But Normalcy?

Assertio Announces Publication of Rolvedon® Same-Day Dosing Clinical Trial — Neutral

ASRT   Business Wire — January 09, 2026

LAKE FOREST, Ill.--(BUSINESS WIRE)--Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced that results of a clinical trial investigating a novel dosing schedule of Rolvedon® (eflapegrastim-xnst) injection have been peer reviewed and published in The Oncologist. In the study of patients with early-stage breast cancer (ESBC), Rolvedon, when administered on the same day (same-day dosing) as TC chemotherapy (Taxotere (docetaxel) and cyclophosphamide) demonstrated an e.

image for news Assertio Announces Publication of Rolvedon® Same-Day Dosing Clinical Trial

LOS ANGELES, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming January 30, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired DeFi Technologies Inc. (“DeFi” or the “Company”) (NASDAQ: DEFT) securities between May 12, 2025 and November 14, 2025, inclusive (the “Class Period”).

image for news Deadline Alert: DeFi Technologies Inc. (DEFT) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

3 Tech Stocks Positioned for the Next Leg of the Bull Market — Positive

AVGO  ORCL  UBER   MarketBeat — January 09, 2026

The first few trading days of January have reminded investors that we're still operating in a manic market. Each of the major indexes has closed at a new all-time high in January, and as of the market opening on Jan. 8, all the indexes were positive for the year.

image for news 3 Tech Stocks Positioned for the Next Leg of the Bull Market